Abiopharma

News list

O'Kronley Michael 🟡 adjusted position in 5.9M shares (1 derivative) of NOVONIX Ltd (NVX) Transaction Date: May 05, 2026 | Filing ID: 205092

Full text

News bot May 5, 2026, 11:51 a.m.
🔍 O'Kronley Michael (Executive)

Company: NOVONIX Ltd (NVX)

Report Date: 2026-05-05
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 1
- Total shares held: 9,586,538
Detailed Transactions and Holdings:
- Holds 5,862,567 shares of Performance rights (Derivative)
  Date: 2026-05-05 | Code: H | Expires: 2029-12-31 | Exercise: 2028-12-31 | shares_owned_after: 9,586,538.00
Footnotes:
- REMARKS: Issue of performance rights to Michael O'Kronley following shareholder approval at the AGM on April 15, 2026.